The role of chemotherapy in squamous cell cancer of the head and neck
Schröder, M.; von Heyden, H.W.
Hno 29(7): 225-239
1981
ISSN/ISBN: 0017-6192 PMID: 7021487 Document Number: 175012
This review article summarizes the results of cytostatic treatment for squamous carcinoma of the head and neck region between 1977 and 1980. The cytostatic therapy is not established yet. Dosage and combination of the three most effective drugs: Methotrexate, Bleomycin and Cis-Platinum seems to be of minor importance for the effectivity than selection of patients for prognostic factors. Primary chemotherapy in not pretreated patients with Karnofsky-Index above 60% is most successful.
Document emailed within 1 workday
Related Documents
Posner, M.R.; Colevas, A.D. 1997: Induction chemotherapy in the management of squamous cell cancer of the head and neck Cancer Journal from Scientific American 3(2): 73-75Greenberg, B.R. 1985: Chemotherapy of squamous cell carcinoma of the head and neck Arizona Medicine 42(7): 411-417
Stathopoulos, G.; Wiltshaw, E.; Price, L.A. 1976: Quadruple chemotherapy in advanced squamous cell carcinoma of the head and neck British Journal of Clinical Practice 30(10): 188-189
Nishino, H.; Abe, K.; Ishikawa, K.; Kanazawa, T.; Tanaka, H.; Miyata, M.; Kitamura, K.; Morita, M. 1999: Combined chemotherapy with low-dose cisplatin, tegafur and uracil for head and neck squamous cell carcinomas Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(11): 1617-1621
Kamnerdsupaphon, P.; Chitapanarux, I.; Lorvidhaya, V.; Sumitsawan, Y.; Tharavichitkul, E.; Sukthomya, V. 2008: Taxotere, cisplatin, fluorouracil, and leucovorin (TPFL)as induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(11): 1869-1873
Vogl, S.E.; Camacho, F.J.; Kaplan, B.H.; O'Donnell, M.R. 1984: Phase Ii trial of vindesine in advanced squamous cell cancer of the head and neck Cancer Treatment Reports 68(3): 559-560
Andratschke, M.; Pauli, C.; Stein, M.; Chaubal, S.; Wollenberg, B. 2003: MHC-class i antigen expression on micrometastases in bone marrow of patients with head and neck squamous cell cancer Anticancer Research 23(2b): 1467-1471
Flohr, J.K.; Lee, J.H. 2008: Identical but different: mechanism of cancer development and response to treatment for human papillomavirus-related and non-related squamous cell cancer of the head and neck South Dakota Medicine: the Journal of the South Dakota State Medical Association 61(12): 453; 455
Rosenthal, D.I.; Sinard, R.J.; Okani, O.; Corak, J.; Kavanaugh, D.; Kamen, B.; Vuitch, F.M.; Gazdar, A.F.; Griener, J.; Frenkel, E.P.; Carbone, D.P. 1997: Seven-week continuous-infusion paclitaxel with concurrent radiotherapy for locally advanced head and neck squamous cell cancer: a phase i study Seminars in Oncology 24(6 Suppl 19: S19
Bender, M.D.; Montgomery, A.C.; Shaw, H.J. 1985: Radical neck dissection for squamous cell carcinoma of the head and neck: early and long-term results of treatment Annals of the Royal College of Surgeons of England 67(1): 47-50
Yokoyama, J. 2002: Present role and future prospect of superselective intra-arterial infusion chemotherapy for head and neck cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(2): 169-175
Tsukuda, M.; Mochimatsu, I.; Kokatsu, T.; Ito, K.; Furukawa, S.; Inoue, T.; Watanabe, S.; Sawaki, S. 1992: Experimental study of CF chemotherapy, combined with another one chemotherapeutic drug against head and neck cancer cell lines Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(4): 553-556
2015: (S004) Combination of radiotherapy and cetuximab for aggressive, high-risk cutaneous squamous cell cancer of the head and neck: a propensity score analysis Oncology 29(4 Suppl. 1)
González-Larriba, J.L.; Garcia Carbonero, I.; Sastre Valera, J.; Perez Segura, P.; Diaz-Rubio, E. 1997: Neoadjuvant therapy with cisplatin/fluorouracil vs cisplatin/UFT in locally advanced squamous cell head and neck cancer Oncology 11(9 Suppl 10: 90-97
Livingston, R.B.; Einhorn, L.H.; Burgess, M.A.; Gottlieb, J.A. 1976: Sequential combination chemotherapy for advanced, recurrent, squamous carcinoma of the head and neck Cancer Treatment Reports 60(1): 103-105
Voravud, N.; Charuruks, N.; Mutirangura, A. 1997: Squamous cell carcinoma of head and neck Journal of the Medical Association of Thailand 80(4): 207-218
Caignard, A.; Dietrich, P.Y.; Morand, V.; Lim, A.; Pannetier, C.; Leridant, A.M.; Hercend, T.; Even, J.; Kourilsky, P.; Triebel, F. 1994: Evidence for T-cell clonal expansion in a patient with squamous cell carcinoma of the head and neck Cancer Research 54(5): 1292-1297
Mayer, A.; Andratschke, M.; Pauli, C.; Graefe, H.; Kristina, K.; Wollenberg, B. 2005: Generation of an autologous cell system for immunotherapy of squamous cell carcinoma of the head and neck Anticancer Research 25(6b): 4075-4080
Yasumura, S.; Hirabayashi, H.; Schwartz, D.R.; Toso, J.F.; Johnson, J.T.; Herberman, R.B.; Whiteside, T.L. 1993: Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck Cancer Research 53(6): 1461-1468
Wagenblast, J.; Hambek, M.; Baghi, M.; Knecht, R. 2008: Effect of bortezomib on EGFR expression in head and neck squamous cell carcinoma cell lines Anticancer Research 28(2a): 687-692